M.I. Garvey
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 19
- Mycobacterium research and diagnosis 7
- Pneumonia and Respiratory Infections 6
-
- Antimicrobial Resistance in Staphylococcus 6
- Infection Control in Healthcare 6
- Co-authors
- Laura J. V. Piddock (7 shared papers)Simon Gibbons (3 shared papers)M. Mukhlesur Rahman (3 shared papers)C.W. Bradley (6 shared papers)M. Wilkinson (10 shared papers)Alison J. Baylay (1 shared paper)Ryan L. Wong (1 shared paper)P. Jumaa (3 shared papers)
- Journals
- Journal of Hospital Infection (14 papers)Antimicrobial Resistance and Infection Control (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Infection Control and Hospital Epidemiology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United KingdomBelgium
In The Last Decade
M.I. Garvey
36 papers receiving 797 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 286
- Applied Microbiology and Biotechnology 36
- Endocrinology 78
- Microbiology 73
- Critical Care and Intensive Care Medicine 61
Countries citing papers authored by M.I. Garvey
This map shows the geographic impact of M.I. Garvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.I. Garvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.I. Garvey more than expected).
Fields of papers citing papers by M.I. Garvey
This network shows the impact of papers produced by M.I. Garvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.I. Garvey. The network helps show where M.I. Garvey may publish in the future.
Co-authors
The 25 scholars most cited alongside M.I. Garvey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 103 | |
| 2 | 2010 | 91 | |
| 3 | 2008 | 84 | |
| 4 | 2008 | 74 | |
| 5 | 2009 | 57 | |
| 6 | 2010 | 51 | |
| 7 | 2017 | 50 | |
| 8 | 2016 | 46 | |
| 9 | 2016 | 31 | |
| 10 | 2007 | 27 | |
| 11 | 2017 | 23 | |
| 12 | 2013 | 19 | |
| 13 | 2018 | 18 | |
| 14 | 2017 | 17 | |
| 15 | 2016 | 13 | |
| 16 | 2021 | 13 | |
| 17 | 2018 | 10 | |
| 18 | 2022 | 10 | |
| 19 | 2017 | 9 | |
| 20 | 2017 | 9 |
About M.I. Garvey
M.I. Garvey is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Critical Care and Intensive Care Medicine and Molecular Biology, having authored 36 papers that have together received 843 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Nosocomial Infections in ICU (8 papers), Mycobacterium research and diagnosis (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Pneumonia and Respiratory Infections (6 papers), Infection Control in Healthcare (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Molecular Medicine (286 citations), Applied Microbiology and Biotechnology (36 citations), Endocrinology (78 citations), Microbiology (73 citations) and Critical Care and Intensive Care Medicine (61 citations). M.I. Garvey has collaborated with scholars based in United Kingdom and Belgium. Frequent co-authors include Laura J. V. Piddock, Simon Gibbons, M. Mukhlesur Rahman, C.W. Bradley, M. Wilkinson, Alison J. Baylay, Ryan L. Wong, P. Jumaa, Jimmy Walker and Tracey A. Martin. Their work appears in journals such as Journal of Hospital Infection, Antimicrobial Resistance and Infection Control, Journal of Antimicrobial Chemotherapy, Infection Control and Hospital Epidemiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.